- Home
- EW vs MET Comparison
EW vs MET Comparison
Compare EW & MET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EW | MET |
|---|---|---|
| Founded | 1958 | 1863 |
| Country | United States | United States |
| Employees | 16000 | 46000 |
| Industry | Industrial Specialties | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.9B | 55.4B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | EW | MET |
|---|---|---|
| Price | $87.45 | $85.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 15 |
| Target Price | ★ $96.37 | $93.93 |
| AVG Volume (30 Days) | ★ 4.8M | 3.2M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.88% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $6,067,600,000.00 | N/A |
| Revenue This Year | $13.39 | $4.40 |
| Revenue Next Year | $9.81 | $4.51 |
| P/E Ratio | $130.94 | ★ $16.82 |
| Revenue Growth | ★ 11.55 | N/A |
| 52 Week Low | $72.30 | $67.33 |
| 52 Week High | $89.60 | $89.62 |
Technical Indicators
Market Signals| Indicator | EW | MET |
|---|---|---|
| Relative Strength Index (RSI) | 54.10 | 57.41 |
| Support Level | $81.73 | $77.59 |
| Resistance Level | $89.48 | N/A |
| Average True Range (ATR) | 2.34 | 1.76 |
| MACD | -0.12 | -0.05 |
| Stochastic Oscillator | 53.58 | 55.10 |
Price Performance
Historical ComparisonAbout EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
About MET MetLife Inc.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.